Therapeutic Plasma Exchange Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. The year-on-year growth of the global therapeutic plasma exchange market for each segment is also provided. Additionally, market-related factors such as favorable reimbursement scenario, expanding applications in chronic diseases, side effects associated with plasmapheresis and historical year-on-year growth have been taken into consideration while estimating the market size.

Global Therapeutic Plasma Exchange Market: Segmentation
Based on disease indication, the global therapeutic plasma exchange market has been segmented into neurological disorders, renal disorders, hematology disorders, metabolic disorders, and others. The neurological disorders segment has been classified into chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, multiple sclerosis, neuromyelitis optica, and Guillain-Barré syndrome. The renal disorders segment has been categorized into post-renal transplant rejection, anti-glomerular basement membrane (anti-GMB) disease, and Wegener’s granulomatosis. The hematology disorders segment has been divided into thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, cryoglobulinemia, multiple myeloma, metabolic disorders, familial hypercholesterolaemia (homozygous), and fulminant Wilson disease. In terms of end-user, the market has been classified into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment is expected to dominate the market during the forecast period.

In terms of region, the global therapeutic plasma exchange market has been segment into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been divided into major countries/sub-regions in each of the regions. These include the U.S., Canada, the U.K., Germany, Russia, France, Italy, Spain, China, Australia, Japan, India, Brazil, GCC Countries, South Africa, and Mexico.

Global Therapeutic Plasma Exchange Market: Competitive Landscape
The report also profiles major players in the global therapeutic plasma exchange market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Asahi Kasei Corporation, Baxter International, Inc., Terumo Corporation, B. Braun Melsungen AG, Fresenius Kabi AG, Kawasumi Laboratories, Inc., Haemonetics Corporation, Cerus Corporation, Hemacare Corporation, and Medica S.p.A.

The global therapeutic plasma exchange market has been segmented as follows:

Global Therapeutic Plasma Exchange Market, by Disease Indication
Neurological Disorders
Chronic Inflammatory Demyelinating Polyneuropathy
Myasthenia Gravis
Multiple Sclerosis
Neuromyelitis Optica
Guillain-Barré Syndrome
Renal Disorders
Post-renal Transplant Rejection
Anti-GBM (Glomerular Basement Membrane) Disease
Wegener’s Granulomatosis
Hematology Disorders
Thrombotic Thrombocytopenic Purpura
Hemolytic Uremic Syndrome
Cryoglobulinemia
Multiple Myeloma
Metabolic Disorders
Familial Hypercholesterolaemia (homozygous)
Fulminant Wilson Disease
Others

Global Therapeutic Plasma Exchange Market, by End-user
Hospitals
Specialty Clinics
Ambulatory Surgical Centers

Global Therapeutic Plasma Exchange Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
Australia & New Zealand
Japan
China
India
Rest of Asia pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.